Tejnaksh Healthcare Ltd Stock Price Today (NSE: TEJNAKSH)
Fundamental Score
Tejnaksh Healthcare Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Tejnaksh Healthcare Ltd share price today is ₹14.27, up +0.00% on NSE/BSE as of 17 February 2026. Tejnaksh Healthcare Ltd (TEJNAKSH) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹33.42 (Cr). The 52-week high for TEJNAKSH share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 19.89x, TEJNAKSH is currently trading below its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 9.42% and a debt-to-equity ratio of 0.04.
Tejnaksh Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Tejnaksh Healthcare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Tejnaksh Healthcare Share Price: A Financial Analysis
One key insight into the Healthcare Service Provider industry is the increasing demand for preventative diagnostics, fueled by a growing awareness of health and wellness. Examining the Tejnaksh Healthcare share price, currently at ₹15.52, requires a detailed analysis beyond just the current market value. A critical metric to consider is the Price-to-Earnings (PE) ratio, which stands at 19.89 for Tejnaksh Healthcare. This suggests investors are willing to pay approximately 19.89 times the company's earnings per share. This is a significant data point when assessing the company's valuation relative to its growth potential.
Comparing Tejnaksh Healthcare Ltd to its sector peers provides a valuable context. While direct comparisons are complex, consider
Suraksha Diagnostic Ltd. The perception of management quality often drives investor confidence and, subsequently, valuation. Thoroughly understanding how the market views the leadership team and strategic direction of Tejnaksh Healthcare is crucial in evaluating its long-term potential relative to peers with varying management strengths and weaknesses. Understanding management capabilities can reveal risks not seen at first glance in the financial statements alone.The Return on Capital Employed (ROCE) of 12.71% is a crucial indicator of Tejnaksh Healthcare's efficiency in generating profits from its capital. A consistent and ideally increasing ROCE strengthens the company's competitive advantage, effectively building a "moat." A higher ROCE compared to competitors suggests that Tejnaksh Healthcare is better at deploying capital, potentially leading to sustained outperformance. However, it's important to understand what's driving ROCE. What initiatives are contributing to this level of profitability? Is it sustainable?
It's vital to remember that this analysis forms a part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. This analysis provides observational insights based on the current data and market conditions. The information presented should not be interpreted as financial advice or a recommendation to buy or sell shares. Further research and professional consultation are advised before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tejnaksh Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TEJNAKSH across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (32.47%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 19.89 vs Industry: 39.28)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.04)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.13x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.83%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (9.42%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-50.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-11.57%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-5.50% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (2.18% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (2.20% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Tejnaksh Healthcare Ltd Financial Statements
Comprehensive financial data for Tejnaksh Healthcare Ltd including income statement, balance sheet and cash flow
About TEJNAKSH (Tejnaksh Healthcare Ltd)
Tejnaksh Healthcare Ltd (TEJNAKSH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹33.42 (Cr). Tejnaksh Healthcare Ltd has delivered a Return on Equity (ROE) of 9.42% and a ROCE of 12.71%. The debt-to-equity ratio stands at 0.04, reflecting the company's capital structure. Investors tracking TEJNAKSH share price can monitor key metrics including P/E ratio, promoter holding of 73.83%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
TEJNAKSH Share Price: Frequently Asked Questions
What is the current share price of Tejnaksh Healthcare Ltd (TEJNAKSH)?
As of 17 Feb 2026, 10:24 am IST, Tejnaksh Healthcare Ltd share price is ₹14.27. The TEJNAKSH stock has a market capitalisation of ₹33.42 (Cr) on NSE/BSE.
Is TEJNAKSH share price Overvalued or Undervalued?
TEJNAKSH share price is currently trading at a P/E ratio of 19.89x, compared to the industry average of 39.28x. Based on this relative valuation, the Tejnaksh Healthcare Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of TEJNAKSH share price?
The 52-week high of TEJNAKSH share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Tejnaksh Healthcare Ltd share price?
Key factors influencing TEJNAKSH share price include quarterly earnings growth (Sales Growth: -11.57%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Tejnaksh Healthcare Ltd a good stock for long-term investment?
Tejnaksh Healthcare Ltd shows a 5-year Profit Growth of 2.20% and an ROE of 9.42%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.04 before investing in TEJNAKSH shares.
How does Tejnaksh Healthcare Ltd compare with its industry peers?
Tejnaksh Healthcare Ltd competes with major peers in the Healthcare Service Provider. Investors should compare TEJNAKSH share price P/E of 19.89x and ROE of 9.42% against the industry averages to determine competitive standing.
What is the P/E ratio of TEJNAKSH and what does it mean?
TEJNAKSH share price has a P/E ratio of 19.89x compared to the industry average of 39.28x. Investors pay ₹20 for every ₹1 of annual earnings.
How is TEJNAKSH performing according to Bull Run's analysis?
TEJNAKSH has a Bull Run fundamental score of 33.3/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TEJNAKSH belong to?
TEJNAKSH operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Tejnaksh Healthcare Ltd share price.
What is Return on Equity (ROE) and why is it important for TEJNAKSH?
TEJNAKSH has an ROE of 9.42%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Tejnaksh Healthcare Ltd generates profits from shareholders capital.
How is TEJNAKSH debt-to-equity ratio and what does it indicate?
TEJNAKSH has a debt-to-equity ratio of 0.04, which indicates conservative financing with low financial risk.
What is TEJNAKSH dividend yield and is it a good dividend stock?
TEJNAKSH offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Tejnaksh Healthcare Ltd shares.
How has TEJNAKSH share price grown over the past 5 years?
TEJNAKSH has achieved 5-year growth rates of: Sales Growth -5.50%, Profit Growth 2.20%, and EPS Growth 2.18%.
What is the promoter holding in TEJNAKSH and why does it matter?
Promoters hold 73.83% of TEJNAKSH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Tejnaksh Healthcare Ltd.
What is TEJNAKSH market capitalisation category?
TEJNAKSH has a market capitalisation of ₹33 crores, placing it in the Small-cap category.
How volatile is TEJNAKSH stock?
TEJNAKSH has a beta of N/A. A beta > 1 suggests the Tejnaksh Healthcare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TEJNAKSH operating profit margin trend?
TEJNAKSH has a 5-year average Operating Profit Margin (OPM) of 32.47%, indicating the company's operational efficiency.
How is TEJNAKSH quarterly performance?
Recent quarterly performance shows Tejnaksh Healthcare Ltd YoY Sales Growth of -11.57% and YoY Profit Growth of -50.00%.
What is the institutional holding pattern in TEJNAKSH?
TEJNAKSH has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Tejnaksh Healthcare Ltd stock.